What happened in optometry this week: January 15-January 19

Blog
Article

Catch up on what happened in optometry during the week of January 15-January 19.

Catch up with what Optometry Times shared this week:

Diplopia in concussion – what is normal? What is abnormal, and when should it go away?

By Jacqueline Theis, OD, FAAO

New developments to progress diagnostic criteria for Mild Traumatic Brain Injury (TBI) are discussed by The Mild Traumatic Brain Injury (TBI) Task Force of the American Congress of Rehabilitation Medicine Brain Injury Special Interest Group.

Read more...

Morrow, Novacel Optical partner in preparation of eProgressive smart glasses launch

By Jordana Joy, Associate Editor

The European companies are collaborating in part of a strategic distribution partnership before the eProgressive smart glasses are available to the public later this year. The smart glasses use switchable lens technology to provide ease and comfort to patients needing progressive lenses.

Read more...

EnVision Summit 2024: Inside the new Optometry Program and glaucoma panel with Dr Danica Marrelli

By Danica Marrelli, OD, FAAO; Emily Kaiser Maharjan, Assistant Managing Editor; Jordana Joy, Associate Editor

Danica Marrelli, OD, FAAO, AAO Dipl, sat down with Optometry Times to chat about the upcoming EnVision Summit 2024, which is set to take place February 16-19 in Puerto Rico. This year, the meeting includes an Optometry Program, which is chaired by Marrelli and Cecelia Koetting, OD, FAAO, DipABO. Marrelli discusses what optometrists can expect from the family-oriented meeting, from exciting geographic atrophy and glaucoma co-managment panels to a built-in kids track to keep loved ones engaged during CE sessions.

Watch the interview here...

Pupillometry responses may be a valuable biomarker of depression

By Lynda Charters

A collaborative study has found that pupillometry as a clinical test may help identify biomarkers for major depressive disorder. The test identifies a subgroup of patients with anticipatory hypo-arousal subserving anhedonia symptomatology.

Read more...

Vietnam's Pediatric Refractive Error Training Center prepares students amid growing myopia cases

By Robert Weiss, BS; Emily Kaiser Maharjan, Assistant Managing Editor; Jordana Joy, Associate Editor

Robert Weiss, former president and CEO of The Cooper Companies, shares some of the latest optometric schooling developments from Vietnam in his work with Optometry Giving Sight, the Brian Holden Foundation, and Hanoi Medical University.

Watch here...

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.